Walgreens Boots Alliance (NASDAQ:WBA) Updates FY 2024 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 2.800-2.950 for the period, compared to the consensus EPS estimate of 3.200. The company issued revenue guidance of -.

Analyst Ratings Changes

WBA has been the topic of a number of recent analyst reports. Bank of America dropped their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an underperform rating on the stock in a research report on Tuesday, March 26th. TD Cowen cut their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a buy rating for the company in a research report on Wednesday, April 3rd. SVB Leerink lowered their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a market perform rating on the stock in a research report on Monday, March 18th. Deutsche Bank Aktiengesellschaft cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating for the company in a research report on Wednesday, April 3rd. Finally, Barclays lowered their target price on Walgreens Boots Alliance from $21.00 to $19.00 and set an underweight rating on the stock in a report on Monday. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of Hold and an average price target of $23.07.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $15.66 on Thursday. Walgreens Boots Alliance has a 1-year low of $14.62 and a 1-year high of $31.32. The company has a 50 day moving average of $16.76 and a 200-day moving average of $20.36. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The firm has a market cap of $13.51 billion, a price-to-earnings ratio of -2.24, a PEG ratio of 0.98 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.16 EPS. On average, equities analysts forecast that Walgreens Boots Alliance will post 3.21 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 6.39%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s payout ratio is presently -14.29%.

Insider Activity at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari bought 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. In related news, CFO Manmohan Mahajan bought 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.